25th Annual Cerebrovascular Update

Join leading experts at the 25^th Annual Cardiovascular Update, a premier event dedicated to advancing stroke care, prevention, and treatment. This conference features in-depth presentations on stroke epidemiology and prevention, the latest innovations in acute ischemic stroke intervention, and updated strategies for medical management of stroke patients.

Attendees will explore new surgical techniques in stroke care, participate in interactive panel discussions on challenging stroke cases, and gain practical insights into stroke nursing care and rehabilitation best practices. Designed for neurologists, neurosurgeons, emergency medicine specialists, and stroke unit nurses, this event provides cutting-edge updates on stroke research, clinical guidelines, and evidence-based treatment strategies.

Don’t miss this opportunity to connect with leaders in stroke medicine, discover emerging technologies in stroke management, and enhance your expertise in comprehensive stroke care.

Keynote: Aditya Swarup Pandey, MD

Aditya S. Pandey, MD specializes in treating individuals who have blood vessel related diseases of the brain and spinal cord (e.g., aneurysms, AVM, stroke, fistulas, cavernomas, bleeding within the brain, etc.) as well as practicing general neurosurgery (spinal disorders, brain tumors, and traumatic brain injury).

Dr. Pandey is able to perform the latest techniques to treat stroke utilizing suction-stent thrombectomy techniques as well as treating the most complex of aneurysms utilizing flow diversion technology. He is one of two neurosurgeons in the Ann Arbor region who are trained to perform both open surgeries and endovascular procedures when treating patients with brain blood vessel related diseases.

Successful Completion
To successfully complete this activity, the required evaluation must be completed no later than Sunday, April 9, 2026. Thereafter, the evaluation will no longer be available and credits will not be issued. No refunds will be offered for failure to complete the required evaluation by the stated deadline.

1. Recommend lifestyle modifications to patients to reduce the risk of primary and secondary stroke based on latest epidemiology and risk factor trends for stroke.
2. Formulate appropriate management plan for blood pressure control in both ischemic and hemorrhagic stroke.
3. Analyze the benefits and risks of current and emerging endovascular techniques for brain aneurysms and other vascular abnormalities.
4. Review the most current, impactful, nationally/internationally recognized clinical stroke trials published within the past year.
5. Evaluate current strategies for managing ICH.
6. Discuss latest advancements in mechanical thrombectomy for acute ischemic stroke.
7. Employ current pharmacotherapy data on anticoagulation and antiplatelet therapy in both primary and secondary prevention of stroke.
8. Discuss factors that should be considered regarding when to restart antithrombotic agents in stroke patients.
9. Review the role of artificial intelligence in stroke care.
10. Critique the role of stenting in treating various venous intracranial conditions.
11. Evaluate how Mobile Stroke Units are changing the delivery of stroke care.
12. Explore the advantages of telestroke in acute stroke triage.
13. Discuss the link between patent foramen ovale and stroke and management options.
14. Review optimal management for stroke in patients with malignancy.
15. Investigate the utility of prolonged cardiac monitoring in patients with stroke.
16. Describe the latest developments in medical and surgical intervention of carotid disease.
17. Review latest evidence-based recommendations for patients with medium and distal vessel occlusions
18. Discuss management options for patients with large vessel occlusions and low NIHSS.

In support of improving patient care, Thomas Jefferson University is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: This educational activity is designated for a maximum of 8.75 AMA PRA Category 1 Credits ^TM . Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses: This activity awards 8.75 nursing contact hours.

Other Healthcare Professionals: This educational activity is designated for 8.75 AMA PRA Category 1 Credit ^TM. Participants should claim only the credit commensurate with the extent of their participation in the activity.

Other Credit
Nursing Pharmacology Credit: This educational activity offers XX nursing pharmacology credit. Qualifying sessions are noted on the agenda.

PA Patient Safety and Risk Credit: This education activity offers XX PA Patient Safety and Risk credit. Qualifying sessions are noted on the agenda.

Agenda
Agenda subject to change without notice.

Cancellation Policy
Requests for refunds must be submitted in writing and received in the Office of CPD two weeks prior to the start date of the course. There will be no refunds after this period.*  Cancellations notified before the two week time frame will incur a 25% administration fee (with a minimum of $20).  Registrants who fail to attend the conference are responsible for the entire fee.  All refunds will be processed after the conference.  The University reserves the right to cancel or postpone this course due to unforeseen circumstances.  In the event of cancellation or postponement, the University will refund registration fees, but is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines or travel agencies.  Email [email protected] - please include the activity name in the subject line. 

*Registration fees will be refunded less a 15% administration fee to international conference registrants who are unable to secure a travel visa. Registrants must provide proof of visa denial. 

 Jefferson Release Policy
Jefferson may record/livestream/photograph this educational activity. These images/recordings, along with your name, may be used in Jefferson publications or on the Jefferson website. If you verbally submit any questions for Q&A sessions, you are agreeing to be recorded and to have that recording available in enduring materials. Once photographed, filmed, recorded, or videotaped, you waive the right of inspection or approval to which such images/recordings may be put and Jefferson has the right to use, publish, reproduce, modify, adapt, and distribute at any time in any manner or medium.

Jefferson HIPAA Policy
As an attendee of this educational activity hosted by Thomas Jefferson University, Jefferson University Physicians, and Thomas Jefferson University Hospitals, Inc. (collectively 'Jefferson'), you may gain access to certain proprietary information ('Confidential Information'), including Protected Health Information ('PHI').

By participating in this educational activity, you agree to maintain the confidentiality of all Confidential Information, including all PHI, obtained from any source. You also agree to take all necessary steps to protect such Confidential Information and shall not directly or indirectly disclose or use it in any manner or for any reason, other than as necessary to complete the educational activity. Further, you agree not to take photographs, record in any manner or otherwise reproduce any such Confidential Information. You understand that any unauthorized use or disclosure of Confidential Information may result in possible legal action against you by Jefferson whose confidentiality is breached.

The Warwick Hotel Rittenhouse Square Philadelphia
220 S 17^th Street
Philadelphia, PA 19103

 Directions

Other Nearby Hotel
Fairfield Inn & Suites by Marriott Downtown/Center City
261 S 13th St. | Philadelphia, PA 19107 
www.marriott.com/phlcc

Mitigation of Relevant Financial Relationships

Thomas Jefferson University adheres to the Standards for Integrity and Independence in Accredited Continuing Education and the policies that supplement the Standards.

All planners, faculty, and others in control of educational content are required to disclose any relevant financial relationships with ACCME defined ineligible companies within the past 24 months. Any conflicts of interests have been mitigated prior to this educational activity. Such disclosures will be available prior to the start of the activity. Jefferson conflict of interest mitigation process may result in changes to the program agenda.

Off-Label/Investigational Use
All faculty/presenters/authors at Thomas Jefferson University sponsored events are required to disclose whether or not their content contains information of commercial products/devices that are unlabeled for use or investigational uses of products not yet approved. Product(s) is/are not included in the labeling approved by the U.S. FDA for the treatment of disease(s).

Content Disclaimer
The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices or Thomas Jefferson University.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products and procedures before using them in clinical practice.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Pascal Jabbour, MD
Professor of Neurological Surgery
Thomas Jefferson Hospital
Philadelphia, PA

Co-Director, Faculty

Consulting Fee-Medtronic (Any division)|Consulting Fee-Siemens|Consulting Fee-Stryker (Any division)|Grant or research support-Medtronic (Any division)|Stocks or stock options, excluding diversified mutual funds-quantanosis|Stocks or stock options, excluding diversified mutual funds-Gravity |Stocks or stock options, excluding diversified mutual funds-Sonorus

Diana L Tzeng, MD
Clinical Associate Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Co-Director, Faculty

Nothing to disclose

Shaista Alam, MD
Clinical Assistant Professor Neurology
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Elias Atallah, MD
Clinical Assistant Professor
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Rodney Bell, MD
Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

Gabriel D Bonnell, MD
Clinical Assistant Professor
Thomas Jefferson University
Philadelphia, PA

Faculty

M. Reid Gooch, MD, FAANS
Assistant Professor of Neurological Surgery
Thomas Jefferson University
Philadelphia, PA

Faculty

Consulting Fee-Stryker (Any division)|Consulting Fee-Rapid Medical|Other: Investor-Sonorus NV

Yevgeniy Isayev, MD
Lehigh Valley Health Network
Stroudsburg, PA

Faculty

Osman Kozak, MD
Abington Health
Abington, PA

Faculty

Nothing to disclose

Elan S Miller, MD
Clinical Assistant Professor of Neurology
Thomas Jefferson University
Philadelphia, PA

Faculty

Shilpi Mittal, MD
Clinical Associate Professor of Neurology
Thomas Jefferson University Hospital
Philadelphia, PA

Faculty

Nothing to disclose

Aditya S Pandey, MD
Professor of Neurosurgery and Chair of Neurosurgery
University of Michigan
Ann Arbor, MI

Faculty

Grant or research support-Medtronic (Any division)|Stocks or stock options, excluding diversified mutual funds-Endovascular Horizons|Royalties or Patent Beneficiary-Histosonics|Stocks or stock options, excluding diversified mutual funds-NextGen Biologics|Stocks or stock options, excluding diversified mutual funds-FlexDex

Richard F Schmidt, MD
Clinical Assistant Professor
Thomas Jefferson University
Sewell, NJ

Faculty

Mijail D Serruya, MD, PhD
Neurologist
Thomas Jefferson University
Merion Station, PA

Faculty

Syed O Shah, MD, MBA
Associate Professor of Neurology and Neurological Surgery
Thomas Jefferson University
Philadelphia, PA

Faculty

Nothing to disclose

Michelle J Smith, MD
Clinical Associate Professor of Neurological Surgery, System Chief of Neurosurgery, Main Line Health, Medical Co-Director Neuroscience Service Line, Main Line Health
Thomas Jefferson University
Bryn Mawr, PA

Faculty

Ryna K Then, MD
Neurology Department Chair
Jefferson Einstein
Philadelphia , NJ

Faculty

Thana N Theofanis, MD
Clinical Assistant Professor of Neurological Surgery
Main Line Health - Jefferson Neurosurgery
Villanova, PA

Faculty

Stavropoula I Tjoumakaris, MD, FAANS, FACS, FAHA
Professor of Neurological Surgery
Thomas Jefferson University, Dept. Neurosurgery
Philadelphia, PA

Faculty

Consulting Fee-Microvention|Consulting Fee-Medtronic|Grant or research support-Microvention

Hekmat Zarzour, MD
Associate Professor
Thomas Jefferson University
Mullica Hill, NJ

Faculty

Nothing to disclose

Maureen DePrince, RN, MSN
Vice President Neuroscience & Behavioral Health Service Line
Thomas Jefferson University Hospital
Philadelphia, PA

Nurse Planner

Nothing to disclose

Exhibitor Rules

• Exhibitor is not providing commercial support for this educational activity. Exhibitor is purchasing exhibit space.

• Exhibits are intended for informational purposes, products should not be sold through the exhibit hall.

• TJU and the exhibitor acknowledge and agree that the exhibitor may be subject to Section 6002 of the Affordable Care Act, which added Section 1128G to the Social Security Act, and its implementing regulations codified in 42 CFR 402 &403 (Collectively the Sunshine Act). Exhibiting companies are solely responsible for collecting any information about actions within their virtual exhibit space that constitutes a payment or transfer of value to a covered participant, which is required to reported under the Sunshine Act.

• Exhibitors may observe educational sessions but must refrain from participating in the activity.

• No recordings of the scientific sessions on behalf of the exhibitor's company is permitted.

Application Deadline
Applications for exhibits will be accepted through Thursday, March 5, 2026. After March 5, 2026, applications may be accepted on a case by case basis.

Cancellation and Refunds
In the event that the symposium is canceled by the organizers, exhibit fees will be refunded in full, however Thomas Jefferson University is not responsible for other expenses incurred by the exhibitor.

In the event an exhibitor cancels participation, refunds will be made as follows:

• Prior to the deadline of March 5, 2026 a refund will be given minus a 10% administration fee.

• After March 5, 2026 no refund will be given.

• Exhibitors who are absent from the conference will not receive a refund.

• Exhibit cancellations must be made in writing.

Send cancellation notice to [email protected] and include name of activity in subject line.